1st Quarter - Amendment
SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC
Client
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 21, 2014 | $350,000 | Replaced |
| 1st Quarter - Amendment (this page) | Oct 29, 2014 | $360,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
orphan drug tax credt; issues surrounding ADHD, including economic and social impact; binge eating disorder; drug shortages;DEA processes; FDA funding and sequester; specialty tiers; track and trace; bundling rules for the Hospital Outpatient Prospective Payment System; compassionate use; step therapy; line extension rebates
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
| JOHN EDWARD GREISSING New | Legal Fellow, Counsel, S. Committee on Judiciary |
| MARK LENKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.